Recent progress toward developing axial chirality bioactive compounds.

Wang, Zheyi; Meng, Liying; Liu, Xinxin; Zhang, Lingzi; Yu, Zongjiang; Wu, Guanzhao

Wang, Zheyi; Meng, Liying; Liu, Xinxin; Zhang, Lingzi; Yu, Zongjiang; Wu, Guanzhao.

Afiliación

Wang Z; Department of Medical Experimental Center, Qilu Hospital (Qingdao), Cheeloo College of Medicine, Shandong University, Qingdao, 266035, China.
Meng L; Department of Medical Experimental Center, Qilu Hospital (Qingdao), Cheeloo College of Medicine, Shandong University, Qingdao, 266035, China.
Liu X; Department of Medical Experimental Center, Qilu Hospital (Qingdao), Cheeloo College of Medicine, Shandong University, Qingdao, 266035, China.
Zhang L; Department of Pharmacy, Qilu Hospital (Qingdao), Cheeloo College of Medicine, Shandong University, Qingdao, 266035, China.
Yu Z; CAS Key Laboratory of Bio-based Materials, Qingdao Institute of BioEnergy and Bioprocess Technology, Chinese Academy of Sciences, Qingdao, 266101, People's Republic of China. Electronic address: yuzj@qibebt.ac.cn.
Wu G; Department of Medical Experimental Center, Qilu Hospital (Qingdao), Cheeloo College of Medicine, Shandong University, Qingdao, 266035, China. Electronic address: guanzhao.wu@email.sdu.edu.cn.

Eur J Med Chem ; 243: 114700, 2022 Dec 05.

Article en En | MEDLINE | ID: mdl-36058089

Asunto(s)

Estereoisomerismo

Palabras clave

Atropisomer; Axial chirality; Axial drugs; Biological activity; Drug discovery

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Estereoisomerismo Idioma: En Revista: Eur J Med Chem Año: 2022 Tipo del documento: Article País de afiliación: China

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google